Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
28577 | 204 | 36.6 | 94% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
578 | 3 | CHEMOKINES//CXCR4//MACROPHAGE MIGRATION INHIBITORY FACTOR | 16225 |
546 | 2 | CHEMOKINES//CXCR4//CHEMOKINE RECEPTOR | 14674 |
28577 | 1 | CXCL16//CXCR6//SR PSOX | 204 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CXCL16 | authKW | 7157723 | 31% | 76% | 63 |
2 | CXCR6 | authKW | 4119845 | 17% | 81% | 34 |
3 | SR PSOX | authKW | 898101 | 3% | 100% | 6 |
4 | CXCL16 CXCR6 | authKW | 449050 | 1% | 100% | 3 |
5 | SR PSOX CXCL16 | authKW | 299367 | 1% | 100% | 2 |
6 | CXC CHEMOKINE LIGAND 16 | authKW | 199577 | 1% | 67% | 2 |
7 | 1ZKF BIOMAT | address | 149683 | 0% | 100% | 1 |
8 | A181V | authKW | 149683 | 0% | 100% | 1 |
9 | AOSMC | authKW | 149683 | 0% | 100% | 1 |
10 | ATHEROSCLEROSIS GENE EXP S | address | 149683 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 427 | 23% | 0% | 47 |
2 | Peripheral Vascular Diseases | 246 | 11% | 0% | 22 |
3 | Rheumatology | 195 | 6% | 0% | 12 |
4 | Oncology | 183 | 17% | 0% | 35 |
5 | Pathology | 134 | 8% | 0% | 16 |
6 | Medicine, Research & Experimental | 77 | 8% | 0% | 17 |
7 | Cardiac & Cardiovascular System | 77 | 9% | 0% | 18 |
8 | Cell Biology | 55 | 10% | 0% | 21 |
9 | Hematology | 47 | 5% | 0% | 11 |
10 | Biophysics | 22 | 5% | 0% | 10 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | 1ZKF BIOMAT | 149683 | 0% | 100% | 1 |
2 | ATHEROSCLEROSIS GENE EXP S | 149683 | 0% | 100% | 1 |
3 | BIOSCI BIOTECHNOL BIOFARMACEUT | 149683 | 0% | 100% | 1 |
4 | CATTEDRA ENDOCRINOL MALATTIE RICAMBIO | 149683 | 0% | 100% | 1 |
5 | CLIN IMMUNOL HEMATOL BRANCH | 149683 | 0% | 100% | 1 |
6 | DIABET OBES METAB MED | 149683 | 0% | 100% | 1 |
7 | INFECTION IMMUN INFLAMMAT | 149683 | 0% | 100% | 1 |
8 | MED NUCL MED PET | 149683 | 0% | 100% | 1 |
9 | PITTSBURGH VA HEALTHCARE SYST DEV 151 U | 149683 | 0% | 100% | 1 |
10 | ST S OXYDANT PATHOL METAB BIOL SANTE | 149683 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS | 1202 | 1% | 0% | 3 |
2 | JOURNAL OF APPLIED BIOMEDICINE | 632 | 0% | 0% | 1 |
3 | ATHEROSCLEROSIS | 499 | 3% | 0% | 6 |
4 | JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | 487 | 1% | 0% | 3 |
5 | JOURNAL OF IMMUNOLOGY | 457 | 6% | 0% | 13 |
6 | INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 419 | 2% | 0% | 4 |
7 | CELL COMMUNICATION AND SIGNALING | 396 | 0% | 0% | 1 |
8 | INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY | 362 | 1% | 0% | 2 |
9 | ARTHRITIS AND RHEUMATISM | 357 | 2% | 0% | 5 |
10 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 314 | 2% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CXCL16 | 7157723 | 31% | 76% | 63 | Search CXCL16 | Search CXCL16 |
2 | CXCR6 | 4119845 | 17% | 81% | 34 | Search CXCR6 | Search CXCR6 |
3 | SR PSOX | 898101 | 3% | 100% | 6 | Search SR+PSOX | Search SR+PSOX |
4 | CXCL16 CXCR6 | 449050 | 1% | 100% | 3 | Search CXCL16+CXCR6 | Search CXCL16+CXCR6 |
5 | SR PSOX CXCL16 | 299367 | 1% | 100% | 2 | Search SR+PSOX+CXCL16 | Search SR+PSOX+CXCL16 |
6 | CXC CHEMOKINE LIGAND 16 | 199577 | 1% | 67% | 2 | Search CXC+CHEMOKINE+LIGAND+16 | Search CXC+CHEMOKINE+LIGAND+16 |
7 | A181V | 149683 | 0% | 100% | 1 | Search A181V | Search A181V |
8 | AOSMC | 149683 | 0% | 100% | 1 | Search AOSMC | Search AOSMC |
9 | BACTERIAL SCAVENGER RECEPTOR | 149683 | 0% | 100% | 1 | Search BACTERIAL+SCAVENGER+RECEPTOR | Search BACTERIAL+SCAVENGER+RECEPTOR |
10 | CHEMOKINE CXC LIGAND 16 | 149683 | 0% | 100% | 1 | Search CHEMOKINE+CXC+LIGAND+16 | Search CHEMOKINE+CXC+LIGAND+16 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | IZQUIERDO, MC , MARTIN-CLEARY, C , FERNANDEZ-FERNANDEZ, B , ELEWA, U , SANCHEZ-NINO, MD , CARRERO, JJ , ORTIZ, A , (2014) CXCL16 IN KIDNEY AND CARDIOVASCULAR INJURY.CYTOKINE & GROWTH FACTOR REVIEWS. VOL. 25. ISSUE 3. P. 317 -325 | 55 | 65% | 5 |
2 | QIU, B , LIU, F , TANG, HP , LIU, J , LIU, L , WEN, J , ZHAO, T , (2016) CO-EXPRESSION OF CXCL16 AND CXCR6 IS A RISK FACTOR FOR POOR PROGNOSIS OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY. VOL. 9. ISSUE 5. P. 5368 -5377 | 29 | 69% | 0 |
3 | LI, Y , FU, LX , ZHU, WL , SHI, H , CHEN, LJ , YE, B , (2015) BLOCKADE OF CXCR6 REDUCES INVASIVE POTENTIAL OF GASTRIC CANCER CELLS THROUGH INHIBITION OF AKT SIGNALING.INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. VOL. 28. ISSUE 2. P. 194 -200 | 22 | 76% | 6 |
4 | ELEWA, U , SANCHEZ-NINO, MD , MAHILLO-FERNANDEZ, I , MARTIN-CLEARY, C , ANA, BS , PEREZ-GOMEZ, MV , FERNANDEZ-FERNANDEZ, B , ORTIZ, A , (2016) CIRCULATING CXCL16 IN DIABETIC KIDNEY DISEASE.KIDNEY & BLOOD PRESSURE RESEARCH. VOL. 41. ISSUE 5. P. 663 -671 | 22 | 76% | 0 |
5 | XU, JM , WENG, MZ , SONG, FB , CHEN, JY , ZHANG, JY , WU, JY , QIN, J , JIM, T , WANG, XL , (2014) BLOCKADE OF THE CXCR6 SIGNALING INHIBITS GROWTH AND INVASION OF HEPATOCELLULAR CARCINOMA CELLS THROUGH INHIBITION OF THE VEGF EXPRESSION.INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. VOL. 27. ISSUE 4. P. 553 -561 | 21 | 72% | 5 |
6 | DOS SANTOS, SM , BLANKENBACH, K , SCHOLICH, K , DORR, A , MONSEFI, N , KEESE, M , LINKE, B , DECKMYN, H , NELSON, K , HARDER, S , (2015) PLATELETS FROM FLOWING BLOOD ATTACH TO THE INFLAMMATORY CHEMOKINE CXCL16 EXPRESSED IN THE ENDOTHELIUM OF THE HUMAN VESSEL WALL.THROMBOSIS AND HAEMOSTASIS. VOL. 114. ISSUE 2. P. 297 -312 | 26 | 57% | 3 |
7 | DREYMUELLER, D , GOETZENICH, A , EMONTZPOHL, C , SOPPERT, J , LUDWIG, A , STOPPE, C , (2016) THE PERIOPERATIVE TIME COURSE AND CLINICAL SIGNIFICANCE OF THE CHEMOKINE CXCL16 IN PATIENTS UNDERGOING CARDIAC SURGERY.JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. VOL. 20. ISSUE 1. P. 104 -115 | 23 | 59% | 1 |
8 | HALD, SM , KISELEV, Y , AL-SAAD, S , RICHARDSEN, E , JOHANNESSEN, C , EILERTSEN, M , KILVAER, TK , AL-SHIBLI, K , ANDERSEN, S , BUSUND, LT , ET AL (2015) PROGNOSTIC IMPACT OF CXCL16 AND CXCR6 IN NON-SMALL CELL LUNG CANCER: COMBINED HIGH CXCL16 EXPRESSION IN TUMOR STROMA AND CANCER CELLS YIELDS IMPROVED SURVIVAL.BMC CANCER. VOL. 15. ISSUE . P. - | 25 | 54% | 5 |
9 | SHEIKINE, Y , SIRSJOE, A , (2008) CXCL16/SR-PSOX - A FRIEND OR A FOE IN ATHEROSCLEROSIS?.ATHEROSCLEROSIS. VOL. 197. ISSUE 2. P. 487-495 | 30 | 54% | 36 |
10 | HATTERMANN, K , BARTSCH, K , GEBHARDT, HH , MEHDORN, HM , SYNOWITZ, M , SCHMITT, AD , MENTLEIN, R , HELD-FEINDT, J , (2016) "INVERSE SIGNALING" OF THE TRANSMEMBRANE CHEMOKINE CXCL16 CONTRIBUTES TO PROLIFERATIVE AND ANTI-APOPTOTIC EFFECTS IN CULTURED HUMAN MENINGIOMA CELLS.CELL COMMUNICATION AND SIGNALING. VOL. 14. ISSUE . P. - | 20 | 71% | 0 |
Classes with closest relation at Level 1 |